Benzinga
Benzinga
Benzinga
martedì, settembre 15

Biodexa Pharmaceuticals PLC

BDRXNASDAQ
Trade with Public
Trade with Public
$1.12
-0.18-13.85%
In chiusura: Sep 14, 5:00 PM EST
$1.11
-0.01-0.89%
Post-mercato: 7:59 PM EST
Utili: I risultati di H1 2026 sono stati pubblicati in data ven set 11th, dopo la chiusura del mercato
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentConfrontaRapporto azionario

Biodexa Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Biodexa Pharmaceuticals (BDRX).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$10000Upside to Avg. PT+900800.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Feb 8, 2024Ladenburg ThalmannAydin HuseynovInitiateBuy$8

Analyst Ratings News

PRO
Watching Biodexa Pharmaceuticals; Zacks Small-Cap Research Gives Stock $10 Price Valuation

Benzinga Newsdesk

PRO
Ladenburg Thalmann Initiates Coverage On Biodexa Pharmaceuticals with Buy Rating, Announces Price Target of $8

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Biodexa Pharmaceuticals (NASDAQ:BDRX) with a Buy rating and announces Price Target of $8.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved